NCT05646485 - Bladder Cancer Screening Trial | Biotech Hunter

Enrollment

1,000

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2028

Conditions

Bladder CancerUrothelial CarcinomaHematuriaSmoking Cessation

Interventions

DIAGNOSTIC_TEST

Urinalysis

"Urine analysis (every 6 months for 2 years); Patients with \<3 red blood cells (RBCs) per high-powered field (HPF) will repeat screening at 6-month intervals for an average of 2 years.~If RBCs are 3-25 RBSc/HPF- subjects will undergo- \[cystoscopy + Upper tract imaging\] or \[urine marker cancer testing with Cxbladder triage + Upper tract imaging\].~If \>25 RBCs, subjects will get - \[cystoscopy + Upper tract imaging\]."

Trial Locations (1)

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas